An elevated LH and a low normal morning testosterone define subclinical hypogonadism, and can be attributed to moderate doses of alkylating agent and low dose of testicular irradiation (<20 Gy); however, subclinical hypogonadism rarely requires exogenous testosterone replacement therapy (99–101). The gene discussed is PLOD1; the disease is hypogonadism.